Latest news

Filter by
Date
Feb 18, 2015 12:00 AM

Mun Hui a Sydney Catalyst 2015 'Top-Up Research Scholar'

Congratulations to Garvan Cancer PhD student Mun Ngah Hui.

MEDIA RELEASE: Feb 02, 2015 09:00 PM

Epigenetic signatures that differentiate triple-negative bre...

Australian researchers have identified epigenetic ‘signatures’ that could help clinicians tell the difference between highly aggressive and more benign forms of triple-negative breast cancer.

MEDIA RELEASE: Nov 11, 2014 03:00 AM

Scientists solve mystery of ‘Frankenstein’ DNA

Scientists from Garvan, the Walter and Eliza Hall Institute of Medical Research and Peter MacCallum Cancer Centre have uncovered how the massive DNA molecules that appear in some tumours are formed like Frankenstein’s mo...

MEDIA RELEASE: Nov 06, 2014 04:00 AM

Bone drug should be seen in a new light for its anti-cancer ...

Australian researchers have shown why calcium-binding drugs commonly used to treat people with osteoporosis, or with late-stage cancers that have spread to bone, may also benefit patients with tumours outside the skeleto...

MEDIA RELEASE: Oct 15, 2014 12:01 AM

Early detection window when pancreatic cancer is in the fami...

Pancreatic cancer likely takes between 10 and 20 years to develop, providing the potential for a very “broad window” of intervention if detected early, which may be possible for people who inherit a predisposition, say A...

MEDIA RELEASE: Sep 29, 2014 12:05 AM

Ancient human genome from southern Africa throws light on ou...

The skeleton of a man who lived 2,330 years ago in the southernmost tip of Africa tells us about ourselves as humans, and throws some light on our earliest common genetic ancestry.

Sep 04, 2014 01:00 AM

Professors Chris Goodnow and Jonathan Sprent receive top-tie...

Congratulations to Professors Chris Goodnow and Jonathan Sprent, recipients of prestigious NHMRC Senior Principal Research Fellowships, which support leaders in their field.

MEDIA RELEASE: Aug 14, 2014 03:00 AM

Moving towards the creation of blood stem cells in the labor...

A team of scientists from the Garvan Institute and Monash University have uncovered a mechanism essential for forming hematopoietic stem cells, a very special group of cells in the early embryo that ultimately generate a...

Jun 12, 2014 12:00 AM

2014 St Vincent's Precinct Three Minute Thesis Competition

Garvan Neuroscience PhD student Ira Deveson, a member of Prof John Mattick’s RNA Biology and Plasticity lab, won the 2014 St Vincent’s Precinct Three Minute Thesis Competition on 12 June.

MEDIA RELEASE: Jan 15, 2014 03:00 AM

The future of genomic medicine has arrived in Australia

The transformation of medicine by human genome sequencing has moved closer following the announcement today that Sydney’s Garvan Institute of Medical Research is one of the first in the world to acquire machines that can...

MEDIA RELEASE: Dec 19, 2013 12:00 AM

David Thomas appointed as new Director of The Kinghorn Cance...

Garvan is very pleased to announce the appointment of Professor David Thomas as the new Director of The Kinghorn Cancer Centre, as well as Head of Garvan’s Cancer Division, from June 2014. The Kinghorn Cancer Centre is a...

MEDIA RELEASE: Sep 16, 2013 02:05 PM

Potential treatment for a specific kind of pancreatic cancer...

Garvan researchers have identified a potentially treatable subtype of pancreatic cancer, which accounts for about 2% of new cases. This subtype expresses high levels of the HER2 gene. HER2-amplified breast and gastric ca...

MEDIA RELEASE: Jul 23, 2013 02:05 PM

New hope for hormone resistant breast cancer

A new finding provides fresh hope for the millions worldwide with oestrogen receptor positive breast cancer. Garvan scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrog...

MEDIA RELEASE: Jun 12, 2013 02:05 PM

Nanotechnology helps track and improve drug action in pancre...

UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny ‘biosensors’ along with new advanced imaging techniques.

MEDIA RELEASE: Dec 29, 2012 01:00 AM

The factor that could determine future breast cancer treatme...

Garvan scientists have shown how a ‘transcription factor’ causes breast cancer to develop an aggressive subtype that lacks sensitivity to oestrogen and does not respond to anti-oestrogen therapies such as Tamoxifen and a...

MEDIA RELEASE: Oct 25, 2012 06:00 PM

Unmasking the deadly secrets of pancreatic cancer

A large-scale study that defines the complexity of underlying mutations responsible for pancreatic cancers in more than 100 patients was published in Nature today.

MEDIA RELEASE: Jul 27, 2012 04:20 PM

What pituitary tumours may tell us about the biology of othe...

Garvan scientists in collaboration with Kolling Institute of Medical Research colleagues have published findings that suggest a DNA repair gene called MGMT might have a greater role to play in the growth of cancers than ...

May 16, 2012 04:28 AM

Chairman outlines key Health and Medical Research issues at ...

Chairman of Garvan, Mr Bill Ferris AC, welcomed The Hon Jillian Skinner (Minister for Health and Minister for Medical Research), as well as incoming Executive Director Professor John Mattick, at this year's Annual Genera...

MEDIA RELEASE: Sep 22, 2011 02:00 PM

Hope for people with Type 2 diabetes – insulin master switch...

Garvan scientists have discovered that a single gene controls a very complex process, apparently forming the crucial link between eating a high fat diet and developing diabetes. Compounds are already being developed for ...

MEDIA RELEASE: Apr 15, 2011 07:00 PM

Helping pancreatic cancer surgeons make tiebreaker decisions...

Garvan researchers have identified two ‘biomarkers’ that appear to have the ability to predict patient survival after surgery for pancreatic cancer before the operation takes place. It is the first predictive tool of its...

MEDIA RELEASE: Jan 17, 2011 06:20 PM

Improved rationale for attacking colorectal cancer

Some people respond very well to chemotherapy or radiotherapy for colorectal cancer, while others hardly respond at all – a fact that has been a bit of a mystery until now. A team of Garvan scientists believes the outcom...